Impax Settles Opana ER Antitrust Direct Buyers’ Class Action For $145M

(July 27, 2022, 8:22 AM EDT) -- CHICAGO — Generic drugmaker Impax Laboratories LLC has agreed to pay $145 million to settle a multidistrict litigation antitrust class action by direct purchasers alleging that the company violated the Sherman...
To view the full article, register now.